Synthesis of intermediate for treprostinil production
US-9611206-B2 · Apr 4, 2017 · US
US10077225B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10077225-B2 |
| Application number | US-201715440441-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 23, 2017 |
| Priority date | Mar 2, 2011 |
| Publication date | Sep 18, 2018 |
| Grant date | Sep 18, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The compound according to Formula I is an intermediate in the synthesis of prostacylin analogs. The present invention provides an efficient method for synthesizing a Formula I compound.
Opening claim text (preview).
What is claimed is: 1. In a process of preparing a pharmaceutical product comprising a prostacyclin, wherein the prostacyclin is synthesized from a starting material of Formula I: the improvement comprising: (I) synthesizing a compound of Formula A by: (i) contacting a compound of Formula B with an organolithium; (ii) contacting the lithiated product from step (i) with copper cyanide to form a cuprate; and (iii) contacting the cuprate from step (ii) with an allyl halide selected from the group consisting of allyl chloride, allyl bromide and allyl iodide; and (II) hydrolyzing the compound of Formula A to form the compound of Formula I, wherein, x is an integer between 2 and 4 inclusive; R is selected from the group consisting of straight or branched (C 1 -C 6 )alkyl, (C 6 -C 14 )aryl, and (C 6 -C 14 )aryl(C 1 -C 6 )alkylene-; and R a , R b and R c are each independently selected from the group consisting of straight or branched (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, (C 6 -C 14 ) aryl, (C 6 -C 14 )aryl(C 1 -C 6 )alkylene, and (C 3 -C 6 )cycloalkyl(C 1 -C 6 )alkylene-. 2. The improvement of claim 1 , wherein R a , R b and R c are each independently (C 1 -C 6 )alkyl. 3. The improvement of claim 2 , wherein R a , R b and R c are each methyl. 4. The improvement of claim 1 , wherein R a is (C 1 -C 6 )alkyl and R b and R c are each independently (C 3 -C 6 )cycloalkyl. 5. The improvement of claim 1 , wherein integer x is 2. 6. The improvement of claim 1 , wherein R is straight or branched (C 1 -C 6 )alkyl. 7. The improvement of claim 1 , wherein R is methyl. 8. The improvement of claim 1 , wherein R is (C 6 -C 14 )aryl(C 1 -C 6 )alkylene-. 9. The improvement of claim 1 , wherein R is benzyl. 10. The improvement of claim 1 , wherein the organolithium is phenyllithium, or butyllithium. 11. The improvement of claim 1 , wherein said hydrolyzing comprises contacting the compound of Formula A with an agent selected from the group consisting of water, aqueous mineral acid, and an aqueous solution of sodium sulfite. 12. The improvement of claim 1 , wherein said hydrolyzing comprises contacting the compound of Formula A with an aqueous solution of sodium sulfite. 13. The improvement of claim 1 , wherein the prostacyclin is treprostinil. 14. In a process of preparing a pharmaceutical product comprising a prostacyclin, wherein the prostacyclin is synthesized from a starting material of Formula I: the improvement comprising: (a) contacting an aldehyde of Formula C with a compound of formula R c R b N—(CHR′) x —NHR a in the presence of an organolithium; wherein x is an integer between 0 and 4 inclusive; R′ is H, R is an alcohol protecting group or is selected from the group consisting of straight or branched (C 1 -C 6 )alkyl, (C 6 -C 14 )aryl, and (C 6 -C 14 )aryl(C 1 -C 6 )alkylene-; and R a , R b and R c are each independently selected from the group consisting of straight or branched (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, (C 6 -C 14 )aryl, (C 6 -C 14 )aryl(C 1 -C 6 )alkylene, and (C 3 -C 6 )cycloalkyl(C 1 -C 6 )alkylene-; (b) contacting the product from step (a) with an organolithium to form an ortho-lithiated product, and then contacting the ortho-lithiated product with copper cyanide to form a cuprate; (c) contacting the cuprate from step (b) with an allyl halide selected from the group consisting of allyl chloride, allyl bromide and allyl iodide; and (d) hydrolyzing the product of step (c) to form the compound of Formula I. 15. The improvement of claim 14 , wherein said organolithium is phenyllithium. 16. The improvement of claim 14 , wherein integer x is 1 and R a , R b and R c are methyl and wherein the allyl halide is allyl iodide. 17. The improvement of claim 14 , wherein the prostacyclin is treprostinil.
containing ether groups, [IMAGE cpc-sch-C07C-0958.gif] groups,[IMAGE cpc-sch-C07C-0959.gif] groups, or[IMAGE cpc-sch-C07C-0960.gif] groups · CPC title
by hydrolysis · CPC title
by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups · CPC title
Preparation of carboxylic acids or their salts, halides or anhydrides (of acids by hydrolysis of oils, fats or waxes C11C) · CPC title
by increase in the number of carbon atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.